The RANP VTE engages in on-going clinical supervision as per a Memorandum of Understanding.
The structure, process and outcome of clinical supervision must be explicit (formal and informal).
The RANP VTE maintains a record of clinical supervision in their professional practice portfolio· To contribute to the continuous improvement of the quality of care experienced by patients with VTE and related issues to diagnosis (i.e.
thrombosis, haemostasis and anticoagulant-related issues).
· The specific contribution of the RANP is to improve outcomes for patients who fall within the RANP scope of practice.
· The RANP will compliment and contribute to the overall service provided by the Department of Haematology.
· The RANP will contribute towards the department's aim of making MMUH Hospital a centre of excellence for the management of patients with venous thromboembolism (VTE).
· To take the lead in developing an Ambulatory DVT Pathway, with the purpose of improving the patient experience, patent safety, reducing emergency department wait times, reducing referrals to the medical on call teams and reducing medical outpatient waiting lists.
· To develop and oversee a safe pathway for the early discharge and community management of patients with low-risk pulmonary emboli, thus reducing the number inpatient hospital bed days.
· To ensure that patients with acute VTE events have early follow-up post-discharge.
This is in accordance with international best practice, and serves the dual purposes of patient education and identifying anticoagulation-related issues early.
In the most recent State Claims Agency report, anticoagulants were the medication group that by far led to the most medication reports in Ireland.
· In line with MMUH Hospital's position as a designated cancer centre and the fact that thrombosis is the second leading cause of death in cancer patients, the VTE RANP would be expected to develop expertise in cancer associated thrombosis (CAT), and co-ordinate a multi-disciplinary team meeting for CAT cases